phenyl acetate has been researched along with Overweight in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 6 (66.67) | 24.3611 |
| 2020's | 2 (22.22) | 2.80 |
| Authors | Studies |
|---|---|
| Bulik, CM; Carroll, IM; Corbin, KD; Crandell, JL; Hooper, J; Igudesman, D; Kosorok, MR; Maahs, DM; Mayer-Davis, EJ; Pence, BW; Pratley, RE; Thomas, JM | 1 |
| Grafetstätter, M; Hirche, F; Johnson, TS; Kaaks, R; Kirsten, R; Kühn, T; Milanese, A; Schübel, R; Sowah, SA; Stangl, GI; Ulrich, CM; Zeller, G | 1 |
| Akerman, M; DeVoti, J; Elera, C; Farzan, S; Khan, S; Tsang, J | 1 |
| Alkhader, M; Gouma, PI; Stanaćević, M | 1 |
| Amer, A; Chen, J; Majumdar, T; Meyers, CD | 1 |
| Costabile, G; Giacco, R; Luongo, D; Naviglio, D; Riccardi, G; Rivellese, AA; Vetrani, C | 1 |
| Djukanovic, L; Jovanovic, D; Lezaic, V; Marinkovic, J; Naumovic, R; Radovic, M; Ristic, G; Simic-Ogrizovic, S; Stanojevic, M; Stosovic, M | 1 |
| Boulet, LP; Busse, WW; Camargo, CA; Emmett, AH; Ferro, TJ; Ortega, HG; Sutherland, ER; Yancey, SW | 1 |
| Choi, YJ; Geaney, JC; Karpf, DB; Krauss, RM; Naim, S; Roberts, BK; Wang, X; Wojnoonski, K | 1 |
1 review(s) available for phenyl acetate and Overweight
| Article | Year |
|---|---|
Body mass index and response to asthma therapy: fluticasone propionate/salmeterol versus montelukast.
Topics: Acetates; Adult; Albuterol; Androstadienes; Anti-Asthmatic Agents; Asthma; Body Mass Index; Cyclopropanes; Double-Blind Method; Drug Combinations; Female; Fluticasone-Salmeterol Drug Combination; Forced Expiratory Volume; Humans; Male; Middle Aged; Multicenter Studies as Topic; Obesity; Overweight; Quinolines; Randomized Controlled Trials as Topic; Sulfides; Time Factors; Treatment Outcome | 2010 |
5 trial(s) available for phenyl acetate and Overweight
| Article | Year |
|---|---|
Associations of Dietary Intake with the Intestinal Microbiota and Short-Chain Fatty Acids Among Young Adults with Type 1 Diabetes and Overweight or Obesity.
Topics: Acetates; COVID-19; Diabetes Mellitus, Type 1; Dietary Fiber; Eating; Fatty Acids, Volatile; Feces; Female; Fructose; Gastrointestinal Microbiome; Humans; Male; Obesity; Overweight; RNA, Ribosomal, 16S; Young Adult | 2023 |
Effectiveness of montelukast in overweight and obese atopic asthmatics.
Topics: Acetates; Adolescent; Anti-Asthmatic Agents; Asthma; Child; Cyclopropanes; Double-Blind Method; Female; Humans; Male; Obesity; Overweight; Prospective Studies; Quinolines; Sulfides | 2017 |
Pharmacokinetics, pharmacodynamics, safety, and tolerability of pradigastat, a novel diacylglycerol acyltransferase 1 inhibitor in overweight or obese, but otherwise healthy human subjects.
Topics: Acetates; Adolescent; Adult; Aminopyridines; Area Under Curve; Diacylglycerol O-Acyltransferase; Dose-Response Relationship, Drug; Double-Blind Method; Female; Half-Life; Humans; Male; Middle Aged; Overweight; Young Adult | 2015 |
Effects of whole-grain cereal foods on plasma short chain fatty acid concentrations in individuals with the metabolic syndrome.
Topics: Acetates; Biomarkers; Blood Glucose; Body Mass Index; Butyrates; C-Reactive Protein; Cholesterol, HDL; Cholesterol, LDL; Diet; Dietary Fiber; Energy Intake; Fatty Acids, Volatile; Female; Humans; Insulin; Interleukin-1alpha; Interleukin-6; Male; Metabolic Syndrome; Middle Aged; Obesity; Overweight; Patient Compliance; Postprandial Period; Propionates; Triglycerides; Tumor Necrosis Factor-alpha; Whole Grains | 2016 |
Effects of the PPAR-δ agonist MBX-8025 on atherogenic dyslipidemia.
Topics: Acetates; Analysis of Variance; Atherosclerosis; Atorvastatin; Biomarkers; Chi-Square Distribution; Double-Blind Method; Drug Therapy, Combination; Dyslipidemias; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Lipoproteins; Male; Middle Aged; Obesity; Overweight; Particle Size; PPAR gamma; Pyrroles; Time Factors; Treatment Outcome; Triazoles | 2012 |
3 other study(ies) available for phenyl acetate and Overweight
| Article | Year |
|---|---|
Changes in Plasma Short-Chain Fatty Acid Levels after Dietary Weight Loss Among Overweight and Obese Adults over 50 Weeks.
Topics: Acetates; Adult; Aged; Butyrates; Caloric Restriction; Diet, Reducing; Fatty Acids, Volatile; Female; Humans; Male; Middle Aged; Nutritional Physiological Phenomena; Obesity; Overweight; Propionates; Time Factors | 2020 |
Metabolic rate monitoring and weight reduction/management.
Topics: Acetates; Acetone; Adipose Tissue; Algorithms; Biomarkers; Breath Tests; Exercise; Exhalation; Health Promotion; Humans; Monitoring, Ambulatory; Obesity; Overweight; Spectroscopy, Fourier Transform Infrared; Weight Loss | 2014 |
Hemodialysis modality, percentage of body fat, and patient survival.
Topics: Acetates; Adiposity; Adult; Aged; Bicarbonates; Cellulose; Dialysis Solutions; Female; Humans; Kidney Diseases; Male; Membranes, Artificial; Middle Aged; Nutritional Status; Overweight; Polymers; Proportional Hazards Models; Prospective Studies; Renal Dialysis; Risk Assessment; Risk Factors; Sulfones; Survival Analysis; Time Factors; Treatment Outcome | 2009 |